公司資料
Pasithea Therapeutics 股價、新聞與催化劑
- 股票代碼:
- KTTA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.51 USD (+3.41%)
收盤價
最後更新: 2026年9月17日
21.6M USD
市值
股價為何變動
截至 2026年9月17日，KTTA 上漲 3.41%，收於 $0.5067。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Pasithea Therapeutics is a biotechnology company focused on neuropsychiatric disorders and inflammation-linked biology. Its story centers on developing treatments for difficult CNS conditions with limited effective options.
所在地與產業分類
Pasithea is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology with a neuroscience angle.
商業模式特徵
The company depends on clinical progress, translational validation, and capital efficiency. Investors generally watch early data, program resets, and whether the company can maintain a coherent development strategy.
生技產業定位
Pasithea occupies a speculative neuroscience niche within biotech. The stock tends to be driven by the market's willingness to underwrite a narrow CNS thesis.
未來催化劑
- Pasithea’s catalysts are oncology and CNS programs, along with any strategic step that clarifies what the company is really building. The stock remains highly dependent on a cleaner path.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。